120 results
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
relating to defeasance;
provisions relating to satisfaction and discharge of the indenture;
any restrictions or conditions on the transferability
8-K
EX-4.2
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy
8-K
EX-4.3
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
) shares of Common Stock to deliver in satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale
8-K
EX-99.1
lcp6mmko90irm4qk2
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
EX-4.1
w7y98y0llav0iyh3r na
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
EX-99.1
c4c47csi0wfgf
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.1
g0a8sy85bdqyepe
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
xsu0u7hn hbgsnc7h
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.2
vc5u21by29vo q9w8
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
p9k47lfujthgq sni1
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
l5ydyre8ce05
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
ynjwp84fu5n1evc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.2
fsz44ea o07se0bul
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.1
gc2th70e ryj9egwru
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
q6vhal5pxffwk5dtc2l
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm